Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery
Clinical and Experimental Ophthalmology2012Vol. 41(4), pp. 387–395
Citations Over TimeTop 15% of 2012 papers
Abstract
There were no cases of uncontrolled intraoperative haemorrhage or serious postoperative choroidal haemorrhage. Mild haemorrhagic oozing during vitrectomy and dispersed vitreous cavity haemorrhage postoperatively were common. For the majority of patients taking antiplatelet or anticoagulant medication, these agents can be safely continued in the vitreoretinal surgical perioperative period.
Related Papers
- → Brief Communication: American Ginseng Reduces Warfarin's Effect in Healthy Patients(2004)235 cited
- Effect of plasma protein binding on the anticoagulant action of warfarin in rats.(1975)
- → Prolonged effects of miconazole oral gel on warfarin anticoagulation even after treatment withdrawal(2016)3 cited
- → Drug focus on warfarin — an anticoagulant medication(2014)1 cited
- → Predicting the Dose of Warfarin for Therapeutic Anticoagulation(1982)14 cited